Aptevo Therapeutics Inc. — Director's Dealing 2019

Nov 6, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2019-11-01

Reporting Person: Lamothe Jeffrey G. (SVP, CFO and Treasurer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-01	Stock Option (right to buy)	$0.576	A	135384	Acquired	2029-10-31	Common Stock (135384)	Direct

Footnotes

F1: The options vest on November 1, 2020, the one-year anniversary of the grant date.